Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $22.3 million.

  • Acadia Healthcare Company's Change in Receivables rose 53062.96% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.4 million, marking a year-over-year increase of 13503.37%. This contributed to the annual value of $2.3 million for FY2024, which is 9403.0% down from last year.
  • Per Acadia Healthcare Company's latest filing, its Change in Receivables stood at $22.3 million for Q3 2025, which was up 53062.96% from $11.7 million recorded in Q2 2025.
  • Acadia Healthcare Company's 5-year Change in Receivables high stood at $31.0 million for Q1 2025, and its period low was -$18.6 million during Q4 2024.
  • Moreover, its 5-year median value for Change in Receivables was $6.4 million (2022), whereas its average is $7.7 million.
  • Over the last 5 years, Acadia Healthcare Company's Change in Receivables had its largest YoY gain of 65761.82% in 2024, and its largest YoY loss of 143144.03% in 2024.
  • Over the past 5 years, Acadia Healthcare Company's Change in Receivables (Quarter) stood at -$11.1 million in 2021, then skyrocketed by 158.24% to $6.4 million in 2022, then tumbled by 118.87% to -$1.2 million in 2023, then tumbled by 1431.44% to -$18.6 million in 2024, then soared by 219.84% to $22.3 million in 2025.
  • Its last three reported values are $22.3 million in Q3 2025, $11.7 million for Q2 2025, and $31.0 million during Q1 2025.